Global Novel Drug Delivery Systems for Cancer Therapy Market Research Report 2024(Status and Outlook)

Global Novel Drug Delivery Systems for Cancer Therapy Market Research Report 2024(Status and Outlook)



Report Overview: The Global Novel Drug Delivery Systems for Cancer Therapy Market Size was estimated at USD 6665.51 million in 2023 and is projected to reach USD 7374.95 million by 2029, exhibiting a CAGR of 1.70% during the forecast period. This report provides a deep insight into the global Novel Drug Delivery Systems for Cancer Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Novel Drug Delivery Systems for Cancer Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market. In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Novel Drug Delivery Systems for Cancer Therapy market in any manner. Global Novel Drug Delivery Systems for Cancer Therapy Market: Market Segmentation Analysis The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments. Key Company Advanced Medical Isotope Corporation Bind Therapeutics Boston Scientific Corporation BTG plc CeloNova BioSciences, Inc. Cook Medical, Inc. Cospheric LLC Covidien, plc Eckert & Ziegler BEBIG EmboMedics, Inc. Kobo Products, Inc. Merit Medical Systems, Inc. Mo-Sci Corporation Nanobiotix Polysciences, Inc. Sirtex Medical, Inc. Terumo Corporation Market Segmentation (by Type) Embolization Particles – Drug Eluting Beads Polyvinyl Alcohol Particles Microspheres Gelatin-Based Embolization Devices Selective Internal Radiation Therapy Holmium-Based Microspheres Liquid Embolics – Onyx Other Market Segmentation (by Application) Hospitals Clinics Others Geographic Segmentation • North America (USA, Canada, Mexico) • Europe (Germany, UK, France, Russia, Italy, Rest of Europe) • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific) • South America (Brazil, Argentina, Columbia, Rest of South America) • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA) Key Benefits of This Market Research: • Industry drivers, restraints, and opportunities covered in the study • Neutral perspective on the market performance • Recent industry trends and developments • Competitive landscape & strategies of key players • Potential & niche segments and regions exhibiting promising growth covered • Historical, current, and projected market size, in terms of value • In-depth analysis of the Novel Drug Delivery Systems for Cancer Therapy Market • Overview of the regional outlook of the Novel Drug Delivery Systems for Cancer Therapy Market: Key Reasons to Buy this Report: • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change • This enables you to anticipate market changes to remain ahead of your competitors • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly • Provision of market value (USD Billion) data for each segment and sub-segment • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis • Provides insight into the market through Value Chain • Market dynamics scenario, along with growth opportunities of the market in the years to come • 6-month post-sales analyst support Customization of the Report In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met. Note: this report may need to undergo a final check or review and this could take about 48 hours. Chapter Outline Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods. Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Novel Drug Delivery Systems for Cancer Therapy Market and its likely evolution in the short to mid-term, and long term. Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market. Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis. Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc. Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years. Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years. Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Novel Drug Delivery Systems for Cancer Therapy
1.2 Key Market Segments
1.2.1 Novel Drug Delivery Systems for Cancer Therapy Segment by Type
1.2.2 Novel Drug Delivery Systems for Cancer Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Novel Drug Delivery Systems for Cancer Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Novel Drug Delivery Systems for Cancer Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Novel Drug Delivery Systems for Cancer Therapy Market Competitive Landscape
3.1 Global Novel Drug Delivery Systems for Cancer Therapy Sales by Manufacturers (2019-2024)
3.2 Global Novel Drug Delivery Systems for Cancer Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Novel Drug Delivery Systems for Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Novel Drug Delivery Systems for Cancer Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Novel Drug Delivery Systems for Cancer Therapy Sales Sites, Area Served, Product Type
3.6 Novel Drug Delivery Systems for Cancer Therapy Market Competitive Situation and Trends
3.6.1 Novel Drug Delivery Systems for Cancer Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Novel Drug Delivery Systems for Cancer Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Novel Drug Delivery Systems for Cancer Therapy Industry Chain Analysis
4.1 Novel Drug Delivery Systems for Cancer Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Novel Drug Delivery Systems for Cancer Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Novel Drug Delivery Systems for Cancer Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Novel Drug Delivery Systems for Cancer Therapy Sales Market Share by Type (2019-2024)
6.3 Global Novel Drug Delivery Systems for Cancer Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Novel Drug Delivery Systems for Cancer Therapy Price by Type (2019-2024)
7 Novel Drug Delivery Systems for Cancer Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Novel Drug Delivery Systems for Cancer Therapy Market Sales by Application (2019-2024)
7.3 Global Novel Drug Delivery Systems for Cancer Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Novel Drug Delivery Systems for Cancer Therapy Sales Growth Rate by Application (2019-2024)
8 Novel Drug Delivery Systems for Cancer Therapy Market Segmentation by Region
8.1 Global Novel Drug Delivery Systems for Cancer Therapy Sales by Region
8.1.1 Global Novel Drug Delivery Systems for Cancer Therapy Sales by Region
8.1.2 Global Novel Drug Delivery Systems for Cancer Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Novel Drug Delivery Systems for Cancer Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Novel Drug Delivery Systems for Cancer Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Novel Drug Delivery Systems for Cancer Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Novel Drug Delivery Systems for Cancer Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Novel Drug Delivery Systems for Cancer Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Advanced Medical Isotope Corporation
9.1.1 Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy Basic Information
9.1.2 Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy Product Overview
9.1.3 Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy Product Market Performance
9.1.4 Advanced Medical Isotope Corporation Business Overview
9.1.5 Advanced Medical Isotope Corporation Novel Drug Delivery Systems for Cancer Therapy SWOT Analysis
9.1.6 Advanced Medical Isotope Corporation Recent Developments
9.2 Bind Therapeutics
9.2.1 Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy Basic Information
9.2.2 Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy Product Overview
9.2.3 Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy Product Market Performance
9.2.4 Bind Therapeutics Business Overview
9.2.5 Bind Therapeutics Novel Drug Delivery Systems for Cancer Therapy SWOT Analysis
9.2.6 Bind Therapeutics Recent Developments
9.3 Boston Scientific Corporation
9.3.1 Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy Basic Information
9.3.2 Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy Product Overview
9.3.3 Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy Product Market Performance
9.3.4 Boston Scientific Corporation Novel Drug Delivery Systems for Cancer Therapy SWOT Analysis
9.3.5 Boston Scientific Corporation Business Overview
9.3.6 Boston Scientific Corporation Recent Developments
9.4 BTG plc
9.4.1 BTG plc Novel Drug Delivery Systems for Cancer Therapy Basic Information
9.4.2 BTG plc Novel Drug Delivery Systems for Cancer Therapy Product Overview
9.4.3 BTG plc Novel Drug Delivery Systems for Cancer Therapy Product Market Performance
9.4.4 BTG plc Business Overview
9.4.5 BTG plc Recent Developments
9.5 CeloNova BioSciences, Inc.
9.5.1 CeloNova BioSciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Basic Information
9.5.2 CeloNova BioSciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Overview
9.5.3 CeloNova BioSciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Market Performance
9.5.4 CeloNova BioSciences, Inc. Business Overview
9.5.5 CeloNova BioSciences, Inc. Recent Developments
9.6 Cook Medical, Inc.
9.6.1 Cook Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Basic Information
9.6.2 Cook Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Overview
9.6.3 Cook Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Market Performance
9.6.4 Cook Medical, Inc. Business Overview
9.6.5 Cook Medical, Inc. Recent Developments
9.7 Cospheric LLC
9.7.1 Cospheric LLC Novel Drug Delivery Systems for Cancer Therapy Basic Information
9.7.2 Cospheric LLC Novel Drug Delivery Systems for Cancer Therapy Product Overview
9.7.3 Cospheric LLC Novel Drug Delivery Systems for Cancer Therapy Product Market Performance
9.7.4 Cospheric LLC Business Overview
9.7.5 Cospheric LLC Recent Developments
9.8 Covidien, plc
9.8.1 Covidien, plc Novel Drug Delivery Systems for Cancer Therapy Basic Information
9.8.2 Covidien, plc Novel Drug Delivery Systems for Cancer Therapy Product Overview
9.8.3 Covidien, plc Novel Drug Delivery Systems for Cancer Therapy Product Market Performance
9.8.4 Covidien, plc Business Overview
9.8.5 Covidien, plc Recent Developments
9.9 Eckert and Ziegler BEBIG
9.9.1 Eckert and Ziegler BEBIG Novel Drug Delivery Systems for Cancer Therapy Basic Information
9.9.2 Eckert and Ziegler BEBIG Novel Drug Delivery Systems for Cancer Therapy Product Overview
9.9.3 Eckert and Ziegler BEBIG Novel Drug Delivery Systems for Cancer Therapy Product Market Performance
9.9.4 Eckert and Ziegler BEBIG Business Overview
9.9.5 Eckert and Ziegler BEBIG Recent Developments
9.10 EmboMedics, Inc.
9.10.1 EmboMedics, Inc. Novel Drug Delivery Systems for Cancer Therapy Basic Information
9.10.2 EmboMedics, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Overview
9.10.3 EmboMedics, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Market Performance
9.10.4 EmboMedics, Inc. Business Overview
9.10.5 EmboMedics, Inc. Recent Developments
9.11 Kobo Products, Inc.
9.11.1 Kobo Products, Inc. Novel Drug Delivery Systems for Cancer Therapy Basic Information
9.11.2 Kobo Products, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Overview
9.11.3 Kobo Products, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Market Performance
9.11.4 Kobo Products, Inc. Business Overview
9.11.5 Kobo Products, Inc. Recent Developments
9.12 Merit Medical Systems, Inc.
9.12.1 Merit Medical Systems, Inc. Novel Drug Delivery Systems for Cancer Therapy Basic Information
9.12.2 Merit Medical Systems, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Overview
9.12.3 Merit Medical Systems, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Market Performance
9.12.4 Merit Medical Systems, Inc. Business Overview
9.12.5 Merit Medical Systems, Inc. Recent Developments
9.13 Mo-Sci Corporation
9.13.1 Mo-Sci Corporation Novel Drug Delivery Systems for Cancer Therapy Basic Information
9.13.2 Mo-Sci Corporation Novel Drug Delivery Systems for Cancer Therapy Product Overview
9.13.3 Mo-Sci Corporation Novel Drug Delivery Systems for Cancer Therapy Product Market Performance
9.13.4 Mo-Sci Corporation Business Overview
9.13.5 Mo-Sci Corporation Recent Developments
9.14 Nanobiotix
9.14.1 Nanobiotix Novel Drug Delivery Systems for Cancer Therapy Basic Information
9.14.2 Nanobiotix Novel Drug Delivery Systems for Cancer Therapy Product Overview
9.14.3 Nanobiotix Novel Drug Delivery Systems for Cancer Therapy Product Market Performance
9.14.4 Nanobiotix Business Overview
9.14.5 Nanobiotix Recent Developments
9.15 Polysciences, Inc.
9.15.1 Polysciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Basic Information
9.15.2 Polysciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Overview
9.15.3 Polysciences, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Market Performance
9.15.4 Polysciences, Inc. Business Overview
9.15.5 Polysciences, Inc. Recent Developments
9.16 Sirtex Medical, Inc.
9.16.1 Sirtex Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Basic Information
9.16.2 Sirtex Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Overview
9.16.3 Sirtex Medical, Inc. Novel Drug Delivery Systems for Cancer Therapy Product Market Performance
9.16.4 Sirtex Medical, Inc. Business Overview
9.16.5 Sirtex Medical, Inc. Recent Developments
9.17 Terumo Corporation
9.17.1 Terumo Corporation Novel Drug Delivery Systems for Cancer Therapy Basic Information
9.17.2 Terumo Corporation Novel Drug Delivery Systems for Cancer Therapy Product Overview
9.17.3 Terumo Corporation Novel Drug Delivery Systems for Cancer Therapy Product Market Performance
9.17.4 Terumo Corporation Business Overview
9.17.5 Terumo Corporation Recent Developments
10 Novel Drug Delivery Systems for Cancer Therapy Market Forecast by Region
10.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast
10.2 Global Novel Drug Delivery Systems for Cancer Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Region
10.2.4 South America Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Novel Drug Delivery Systems for Cancer Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Novel Drug Delivery Systems for Cancer Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Novel Drug Delivery Systems for Cancer Therapy by Type (2025-2030)
11.1.2 Global Novel Drug Delivery Systems for Cancer Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Novel Drug Delivery Systems for Cancer Therapy by Type (2025-2030)
11.2 Global Novel Drug Delivery Systems for Cancer Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Novel Drug Delivery Systems for Cancer Therapy Sales (K Units) Forecast by Application
11.2.2 Global Novel Drug Delivery Systems for Cancer Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings